Is Selinisol (Silvio) an injectable drug or an oral tablet and its usage instructions?
Selinexor (Selinexor) is a new type of selective nuclear export inhibitor (SINE), mainly used to treat patients with multiple myeloma and refractory relapsed lymphoma. It inhibits the function of XPO1 protein and causes tumor suppressor proteins to accumulate in the nucleus, thereby inducing tumor cell apoptosis and achieving anti-tumor effects. The drug has shown promising anti-tumor activity in clinical trials and has been approved in a variety of relapsed or refractory tumors.
Selinisol is mainly taken as an oral tablet, not an injectable drug. The convenience of oral administration allows patients to receive treatment without hospitalization, improving the feasibility and compliance of long-term medication. The specifications and dosage of selinesol tablets vary according to different indications and treatment plans, and are generally adjusted individually by professional doctors based on the patient's weight, severity of illness, and previous treatment.
The commonly used clinical oral regimen of selinesol is usually taken a fixed number of times a week, such as once or twice a week, and the specific dosage needs to follow the doctor's prescription. Tablets should be swallowed whole and avoid chewing or crushing to ensure slow release and stable absorption of the drug. During the medication period, patients need to take the medication on time with meals or on an empty stomach. The specific regimen should be adjusted according to the doctor's recommendations and the patient's tolerance. If mild adverse reactions occur, symptomatic treatment or dose adjustment can be carried out under the guidance of a doctor.
During the use of selinesol, patients should pay close attention to hematological indicators, liver and kidney function, and potential adverse reactions, such as nausea, fatigue, thrombocytopenia, etc. Although oral administration is convenient, you still need to strictly abide by the dosage and medication intervals. Do not increase or decrease the dosage on your own or stop medication at will. Patients should conduct monitoring and follow-up under the guidance of professional doctors to ensure efficacy while reducing the risk of side effects, and seek medical treatment promptly when serious adverse reactions occur.
Reference link:https://www.drugs.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)